The role of oxidative stress in an equine model of human asthma

Redox Report

Volumn 11, Issue 2, 2006, Pages 46-52

  Deaton, Christopher M ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Asthma; Oxidative stress; Recurrent airway obstruction

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASCORBIC ACID DERIVATIVE; PLACEBO; SELENIUM;

AIRWAY OBSTRUCTION; ANIMAL MODEL; ASTHMA; BRONCHOSPASM; BRONCHUS MUCUS; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; HORSE; HUMAN; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; ORGANIC DUST; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; REVIEW;

ANIMALS; ANTIOXIDANTS; ASTHMA; DISEASE MODELS, ANIMAL; HORSE DISEASES; HORSES; HUMANS; LUNG; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANIMALIA; EQUIDAE;

EID: 33746377964     PISSN: 13510002     EISSN: 13510002     Source Type: Journal    
DOI: 10.1179/135100006X101057     Document Type: Review

References (64)

1. Bice DE, Seagrave J, Green FH. Animal models of asthma: potential usefulness for studying health effects of inhaled particles. Inhal Toxicol 2000; 12: 829-862.
2. Fernandes DJ, Xu KF, Stewart AG. Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling. Clin Exp Pharmacol Physiol 2001; 28: 619-629.
3. McGorum BC, Dixon PM, Halliwell RE. Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens. Equine Vet J 1993; 25: 261-267.
4. Pirie RS, Collie DD, Dixon PM, McGorum BC. Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin Exp Allergy 2003; 33: 676-683.
5. Derksen FJ, Scott JS, Miller DC, Slocombe RF, Robinson NE. Bronchoalveolar lavage in ponies with recurrent airway obstruction (heaves). Am Rev Respir Dis 1985; 132: 1066-1070.
6. Lowell FC. Observations on heaves. An asthma-like syndrome in the horse. Allergy Proc 1990; 11: 149-150, discussion 147-148.
7. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-1539.
8. Barbato A, Panizzolo C, Gheno M et al. Bronchoalveolar lavage in asthmatic children: evidence of neutrophil activation in mild-to-moderate persistent asthma. Pediatr Allergy Immunol 2001; 12: 73-77.
9. Boschetto P, Mapp CE, Picotti G, Fabbri LM. Neutrophils and asthma. Eur Respir J Suppl 1989; 6: 456s-459s.
10. Snapper JR. Large animal models of asthma. Am Rev Respir Dis 1986; 133: 351-352.
11. Bureau F, Bonizzi G, Kirschvink N et al. Correlation between nuclear factor-kappalB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000; 161: 1314-1321.
12. Gray PR, Derksen FJ, Broadstone RV, Robinson NE, Peters-Golden M. Decreased airway mucosal prostaglandin E2 production during airway obstruction in an animal model of asthma. Am Rev Respir Dis 1992; 146: 586-591.
13. Anton F, Leverkoehne I, Mundhenk L, Thoreson WB, Gruber AD. Overexpression of eCLCA1 in small airways of horses with recurrent airway obstruction. J Histochem Cytochem 2005; 53: 1011-1021.
14. Turlej RK, Fievez L, Sandersen CF et al. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signalling pathway. Thorax 2001; 56: 696-702.
15. Deaton CM, Marlin DJ, Smith NC et al. Effect of acute airway inflammation on the pulmonary antioxidant status. Exp Lung Res 2005; 31: 653-670.
16. Deaton CM. Systemic and pulmonary antioxidant status and oxidative stress in the horse: effects of airway inflammation, ozone and exercise. Unpublished PhD Thesis, Imperial College London, 2004.
17. Kelly FJ, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet 1999; 354: 482-483.
18. Art T, Kirschvink N, Smith N, Lekeux P. Indices of oxidative stress in blood and pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction. Equine Vet J 1999; 31: 397-401.
19. Deaton CM, Marlin DJ, Roberts CA et al. Antioxidant supplementation and pulmonary function at rest and exercise. Equine Vet J Suppl 2002; 34: 58-65.
20. Kramaric P, Pavlica Z, Koklic T, Nemec A, Erzen NK, Sentjurc M. Membrane switch hypothesis. 2. Domain structure of phagocytes in horses with recurrent airway obstruction. J Chem Inf Model 2005; 45: 1708-1715.
21. Deaton CM, Marlin DJ, Smith NC et al. Pulmonary epithelial lining fluid and plasma ascorbic acid concentrations in horses affected by recurrent airway obstruction. Am J Vet Res 2004; 65: 80-87.
22. Deaton CM, Marlin DJ, Smith NC et al. Antioxidant and inflammatory responses of healthy horses and horses affected by recurrent airway obstruction to inhaled ozone. Equine Vet J 2005; 37: 243-249.
23. Marlin DJ, Johnson L, Kingston DA et al. Application of the comet assay for investigation of oxidative DNA damage in equine peripheral blood mononuclear cells. J Nutr 2004; 134: 2133S-2140S.
24. Fairbairn SM, Page CP, Lees P, Cunningham FM. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin Exp Allergy 1993; 23: 821-828.
25. Marr KA, Foster AP, Lees P, Cunningham FM, Page CP. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. Res Vet Sci 1997; 62: 253-260.
26. Brazil TJ. Pulmonary neutrophil recruitment, activation and clearance in equine chronic obstructive pulmonary disease. Unpublished PhD Thesis, University of Edinburgh, 1999.
27. Nualart FJ, Rivas CI, Montecinos VP et al. Recycling of vitamin C by a bystander effect. J Biol Chem 2003; 278: 10128-10133.
28. Koshiishi I, Mamura Y, Liu J, Imanari T. Degradation of dehydroascorbate to 2,3-diketogulonate in blood circulation. Biochim Biophys Acta 1998; 1425: 209-214.
29. Kirschvink N, Smith N, Fievez L et al. Effect of chronic airway inflammation and exercise on pulmonary and systemic antioxidant status of healthy and heaves-affected horses. Equine Vet J 2002; 34: 563-571.
30. Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 1999; 277: 1,1067-1,1088.
31. Bilzer M, Lauterburg BH. Glutathione metabolism in activated human neutrophils: stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species. Eur J Clin Invest 1991; 21: 316-3220
32. Doucet MY, Jones TR, Ford-Hutchinson AW. Responses of equine trachealis and lung parenchyma to methacholine, histamine, serotonin, prostanoids, and leukotrienes in vitro. Can J Physiol Pharmacol 1990; 68: 379-383.
33. Yu MF, Wang ZW, Robinson NE, Derksen FJ. Modulation of bronchial smooth muscle function in horses with heaves. J Appl Physiol 1994; 77: 2149-2154.
34. Olszewski MA, Robinson NE, Zhu FX, Zhang XY, Tithof PK. Mediators of anaphylaxis but not activated neutrophils augment cholinergic responses of equine small airways. Am J Physiol 1999; 276: L522-L529.
35. Olszewski MA, Zhang XY, Robinson NE. Pre- and postjunctional effects of inflammatory mediators in horse airways. Am J Physiol 1999; 277: L327-L333.
36. Gray PR, Derksen FJ, Robinson NE, Carpenter-Deyo LJ, Johnson HG, Roth RA. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. Am Rev Respir Dis 1989; 140: 154-160.
37. Robinson NE, Derksen FJ, Olszewski MA, Buechner-Maxwell VA. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1995; 152: 283-306.
38. Stewart RM, Weir EK, Montgomery MR, Niewoehner DE. Hydrogen peroxide contracts airway smooth muscle: a possible endogenous mechanism. Respir Physiol 1981; 45: 333-342.
39. Misawa M, Nakano E. Airway constriction by xanthine/xanthine oxidase in guinea pigs in vivo. J Toxicol Environ Health 1993; 39: 193-205.
40. Olszewski MA, Robinson NE, Yu MF, Derksen FJ. Effects of hydrogen peroxide on isolated trachealis muscle of horses. Am J Vet Res 1995; 56: 1479-1485.
41. Kirschvink N, Bureau F, Art T, Lekeux P. Bronchoconstrictive properties of inhaled 8-epi- PGF2alpha in healthy and heaves-susceptible horses. Vet Res 2001; 32: 397-407.
42. Hallahan AR, Armour CL, Black JL. Products of neutrophils and eosinophils increase the responsiveness of human isolated bronchial tissue. Eur Respir J 1990; 3: 554-558.
43. Kanazawa H, Shiraishi S, Okamoto T, Hirata K, Yoshikawa J. Inhibition of bronchoprotective effects of beta2-adrenoceptor agonists by peroxynitrite in guinea pig airways. Am J Respir Crit Care Med 1999; 159: 1272-1276.
44. Kanazawa H, Hirata K, Yoshikawa J. Administration of SIN-1 induces guinea pig airway hyperresponsiveness through inactivation of airway neutral endopeptidase. Int Arch Allergy Immunol 1999; 120: 317-322.
45. Rabe KF, Dent G, Magnussen H. Hydrogen peroxide contracts human airways in vitro: role of epithelium. Am J Physiol 1995; 269: L332-L338.
46. Matera MG, Calzetta L, Peli A, Scagliarini A, Matera C, Cazzola M. Immune sensitization of equine bronchus: glutathione, IL-1beta expression and tissue responsiveness. Respir Res 2005; 6: 104.
47. Casoni GL, Chitano P, Pinamonti S et al. Reducing agents inhibit the contractile response of isolated guinea-pig main bronchi. Clin Exp Allergy 2003; 33: 999-1004.
48. Bureau F, Delhalle S, Bonizzi G et al. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol 2000; 165: 5822-5830.
49. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157: 1630-1637.
50. Antonicelli F, Parmentier M, Drost EM et al. Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells. Free Radic Biol Med 2002; 32: 492-502.
51. Franchini M, Gill U, von Fellenberg R, Bracher VD. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am J Vet Res 2000; 61: 1369-1374.
52. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med 1999; 4: 223-230.
53. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005; 25: 552-563.
54. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429: 195-207.
55. Abu-Khader AA, Bilto YY. Exposure of human neutrophils to oxygen radicals causes loss of deformability, lipid peroxidation, protein degradation, respiratory burst activation and loss of migration. Clin Hemorheol Microcirc 2002; 27: 57-66.
56. Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol 2002; 32: 393-403.
57. Gerber V, Robinson NE, Venta RJ, Rawson J, Jefcoat AM, Hotchkiss JA. Mucin genes in horse airways: MUC5AC, but not MUC2, may play a role in recurrent airway obstruction. Equine Vet J 2003; 35: 252-257.
58. Casalino-Matsuda SM, Monzon ME, Forteza RM. EGFR Activation by EGF mediates oxidant-induced goblet cell metaplasia in human airway epithelium. Am J Respir Cell Mol Biol 2006; 34: 581-591.
59. Takeyama K, Dabbagh K, Jeong Shim J, Dao-Pick T, Ueki IF, Nadel JA. Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol 2000; 164: 1546-1552.
60. Bartner LR, Robinson NE, Kiupel M, Tesfaigzi Y. Persistent mucus accumulation-A consequence of delayed bronchial mucous cell apoptosis in RAO-affected horses? Am J Physiol 2006; doi 10.1165/rcmb.2005-03860C.
61. Kirschvink N, Fievez L, Bougnet V et al. Effect of nutritional antioxidant supplementation on systemic and pulmonary antioxidant status, airway inflammation and lung function in heaves-affected horses. Equine Vet J 2002; 34: 705-712.
62. Snow DH, Frigg M. Oral administration of different formulations of ascorbic acid to the horse. J Equine Vet Sci 1989; 9: 30-33.
63. Deaton CM, Marlin DJ, Smith NC, Harris PA, Schroter RC, Kelly FJ. Antioxidant supplementation in horses affected by recurrent airway obstruction. J Nutr 2004; 134: 2065S-2067S.
64. Deaton CM, Marlin DJ, Smith NC et al. Pulmonary bioavailability of ascorbic acid in an ascorbate-synthesising species, the horse. Free Radic Res 2003; 37: 461-467.